 |
|
|
|||||
Biocon share price: Shares of Biocon Ltd rose 3% after Biocon Pharma received FDA approvals for cancer drugs Lenalidomide and Dasatinib, enhancing its US oncology market presence. The company also got tentative approval for Rivaroxaban. Despite recent stock declines, analysts suggest a potential 22% upside. Biocon's Q3 profits dropped sharply due to a previous one-time gain.
Category:
News and Media
Even though FIIs have pulled out a record amount in Rs 2.1 trillion since October 2024, DIIs have stepped in with even higher investments (Rs 3.2 trillion), keeping the market from falling sharply.
Category:
News and Media
In the Nifty500 pack, seven stocks' close prices crossed above their 200 DMA (Daily Moving Averages) on March 4, according to stockedge.com's technical scan data. The 200-day DMA is used as a key indicator by traders for determining the overall trend in a particular stock. As long as the stock is priced above the 200-day SMA on the daily time frame, it is generally considered to be an overall uptrend. Take a look:
Category:
News and Media
All news |
||||||||||||||||||
|
||||||||||||||||||